Search results
Results from the WOW.Com Content Network
The most common form is caused by a genetic condition called congenital red–green color blindness (including protan and deutan types), which affects up to 1 in 12 males (8%) and 1 in 200 females (0.5%) [3]. The condition is more prevalent in males, because the opsin genes responsible are located on the X chromosome. [2]
Deutan: (6% of males): lacking, or possessing anomalous M-opsins for medium-wavelength-sensitive cone cells. Despite often being called red-blind and green-blind respectively, protan and deutan varieties have very similar phenotypes (color vision), especially when compared to tritan color blindness.
The most common side effects of tramadol in order of decreasing incidence are: [1] [2 ... Serious adverse effects are in bold. Very common (>10% frequency) ...
Protandim is a herbal dietary supplement marketed with unsupported claims that it can treat a number of medical conditions. The product is a patented [1] mix of five herbal ingredients and sold by LifeVantage Corporation (formerly LifeLine Therapeutics, Lifeline Nutraceuticals, and Yaak River Resources, Inc), a Utah-based multi-level marketing company. [2]
There is a distinction between geriatrics and gerontology. Gerontology is the multidisciplinary study of the aging process, defined as the decline in organ function over time in the absence of injury, illness, environmental risks or behavioral risk factors. [5] However, geriatrics is sometimes called medical gerontology.
Frailty can lead to increased risk of adverse side effects, complications, and mortality. [12] Older age by itself is not what defines frailty, it is however a syndrome found in older adults. Many adults over 65 are not living with frailty. [13] Frailty is not one specific disease, however is a combination of many factors.
Between 2000 and 2050, the number of people in the world who are over age 60 is predicted increase from 605 million to 2 billion. [6] The proportion of older adults is already high and continuing to increase in more developed countries. In 2010, seniors (aged 65 and older) made up 13% and 23% of the populations of the US and Japan, respectively.
Comparison of the nonsteroidal antiandrogen (NSAA) bicalutamide with other antiandrogens reveals differences between the medications in terms of efficacy, tolerability, safety, and other parameters. Relative to the other first-generation NSAAs , flutamide and nilutamide , bicalutamide shows improved potency , efficacy, tolerability, and safety ...